» Articles » PMID: 8959655

Prognosis for Canine Malignant Mammary Tumors Based on TNM and Histologic Classification

Overview
Journal J Vet Med Sci
Date 1996 Nov 1
PMID 8959655
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The 2-year prognosis of malignant mammary tumors seen in 175 bitches in the Tokyo metropolitan area was assessed based on their TNM clinical staging and histological classification. The larger the tumor size became (T category), the poorer was the clinical prognosis. The 2-year survival rates of the animals with regional lymph node metastasis of tumor cells (N1, N2 category) and/or distant metastasis (M1 category) were markedly lower than those of the animals without such involvement. As the grade of TNM staging increased, the prognosis was poorer, however, there were no significant differences in survival rates among subtypes of adenocarcinomas (tubular, papillary and papillary cystic) determined by WHO histological classification. It was also noticed that animals having carcinomas without tubular formation or myoepithelial cell proliferation had a lower survival rate than animals having carcinomas with those characteristics; and invasive carcinomas into adjacent skin or lymphatic/vascular vessels implied a poorer prognosis than non-invasive ones. The results suggest that a combined practice of TNM system and our evaluation on the above-mentioned 4 histologic features could be useful for prognostic determination of canine mammary cancers.

Citing Articles

Epidemiological investigation and surgical treatment of canine mammary tumors in Dalian, China, from 2019 to 2023.

Jing Z, Feng J, Jin H PLoS One. 2024; 19(11):e0314292.

PMID: 39576831 PMC: 11584073. DOI: 10.1371/journal.pone.0314292.


Enhancing electrochemical detection through machine learning-driven prediction for canine mammary tumor biomarker with green silver nanoparticles.

Enginler S, Kucukdeniz T, Dal G, Yildirim F, Cilasun G, Alkan F Anal Bioanal Chem. 2024; 416(23):5071-5088.

PMID: 39031228 PMC: 11377509. DOI: 10.1007/s00216-024-05444-0.


Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies.

Nosalova N, Huniadi M, Hornakova L, Valencakova A, Hornak S, Nagoos K Int J Mol Sci. 2024; 25(5).

PMID: 38474142 PMC: 10931591. DOI: 10.3390/ijms25052891.


evaluation of the antitumor activity of axitinib in canine mammary gland tumor cell lines.

Lee H, Lim G, An J, Park S, Seo K, Youn H J Vet Sci. 2024; 25(1):e1.

PMID: 38311316 PMC: 10839173. DOI: 10.4142/jvs.23191.


Expression of acetylated histones H3 and H4 and histone deacetylase enzymes HDAC1, HDAC2 and HDAC6 in simple mammary carcinomas of female dogs.

Senhorello I, Matiz O, Canavari I, Hernandez G, Anai L, Ampuero R Front Genet. 2023; 14:1257932.

PMID: 38028583 PMC: 10666162. DOI: 10.3389/fgene.2023.1257932.